Restera Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
11
- Latest Deal Type
-
Series B
- (Cancelled)
- Investors
-
14
Restera General Information
Description
Operator of a clinical-stage medical technology company intended for advanced sleep apnea treatments. The company offers innovative treatments for sleep apnea that go beyond technical specifications, focusing on enhancing patient outcomes, simplifying surgical procedures, and advancing the future of sleep apnea treatment through continuous innovation and a patient-centered approach, enabling healthcare providers to improve patient care and increase the number of procedures performed daily.
Contact Information
Website
www.resterasleep.comCorporate Office
- 3930 Freedom Circle
- Suite 120
- Santa Clara, CA 95054
- United States
Corporate Office
- 3930 Freedom Circle
- Suite 120
- Santa Clara, CA 95054
- United States
Restera Timeline
Restera Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC (Series B) | 10-Jul-2024 | Cancelled | Clinical Trials - General | |||
| 6. Accelerator/Incubator | 29-May-2024 | Completed | Clinical Trials - General | |||
| 5. Later Stage VC | 19-Jan-2024 | Cancelled | Clinical Trials - General | |||
| 4. Later Stage VC (Series A) | 21-Apr-2023 | Completed | Clinical Trials - General | |||
| 3. Later Stage VC | 01-Oct-2021 | Completed | Clinical Trials - General | |||
| 2. Later Stage VC | 02-Jan-2018 | $21M | $27.6M | Completed | Product Development | |
| 1. Early Stage VC (Series A) | 12-Jul-2016 | $6.6M | $6.6M | Completed | Product Development |
Restera Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Restera Comparisons
Industry
Financing
Details
Restera Competitors (7)
One of Restera’s 7 competitors is Nyxoah, a Formerly VC-backed company based in Mont-Saint-Guibert, Belgium.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Nyxoah | Formerly VC-backed | Mont-Saint-Guibert, Belgium | ||||
| ResMed | Corporation | San Diego, CA | ||||
| XII Medical | Venture Capital-Backed | Union City, CA | ||||
| Inspire Medical Systems | Formerly VC-backed | Golden Valley, MN | ||||
| Cryosa | Venture Capital-Backed | Arden Hills, MN |
Restera Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Restera Patents
Restera Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240307684-A1 | Methods for positioning signal delivery devices to treat sleep apnea, and associated devices and treatments | Active | 17-Mar-2023 | ||
| US-12246175-B2 | Methods for positioning signal delivery devices to treat sleep apnea, and associated devices and treatments | Active | 17-Mar-2023 | ||
| US-20250001171-A1 | Methods for positioning signal delivery devices to treat sleep apnea, and associated devices and treatments | Pending | 17-Mar-2023 | ||
| US-11964154-B1 | Signal delivery devices to treat sleep apnea, and associated methods and systems | Active | 22-Dec-2022 | ||
| EP-4389199-A1 | Signal delivery devices to treat sleep apnea, and associated methods and systems | Pending | 22-Dec-2022 | A61N1/3611 |
Restera Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Restera Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| MedTech Innovator | Accelerator/Incubator | |||
| Aphelion Capital | Venture Capital | Minority | ||
| Forepont Capital Partners | Venture Capital | Minority | ||
| Seraph | Venture Capital | Minority | ||
| ShangBay Capital | Venture Capital | Minority |
Restera FAQs
-
When was Restera founded?
Restera was founded in 2013.
-
Where is Restera headquartered?
Restera is headquartered in Santa Clara, CA.
-
What is the size of Restera?
Restera has 11 total employees.
-
What industry is Restera in?
Restera’s primary industry is Therapeutic Devices.
-
Is Restera a private or public company?
Restera is a Private company.
-
What is Restera’s current revenue?
The current revenue for Restera is .
-
How much funding has Restera raised over time?
Restera has raised $56.3M.
-
Who are Restera’s investors?
MedTech Innovator, Aphelion Capital, Forepont Capital Partners, Seraph, and ShangBay Capital are 5 of 14 investors who have invested in Restera.
-
Who are Restera’s competitors?
Nyxoah, ResMed, XII Medical, Inspire Medical Systems, and Cryosa are some of the 7 competitors of Restera.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
